
Fynalax 5mg Tablet
Marketer
Simcare Pharma
Salt Composition
Bisacodyl (5mg)
Overview Fynalax 5mg Tablet
ConstiCare 5mg tablets relieve constipation. This laxative promotes bowel movements, and is sometimes administered pre-operatively in hospitals. Its mechanism involves stimulating intestinal motility. For constipation relief, take ConstiCare 5mg at bedtime, swallowing whole; do not crush or chew. Begin with the lowest effective dose, increasing only if needed, but never exceeding the maximum daily dose. Use should not surpass the recommended duration unless directed by a physician. Lifestyle modifications such as increased fluid intake, regular physical activity, and a diet rich in fiber (fruits, vegetables, grains) can aid in managing constipation. Common, typically transient side effects include nausea, vomiting, and abdominal discomfort. Persistent symptoms warrant medical consultation. Inform your physician of bowel obstructions, persistent digestive upset, or unusually altered bowel habits lasting over two weeks before starting ConstiCare. Certain medications and foods may interact; discuss potential interactions with your doctor to ensure safe usage. Avoid concurrent use with other laxatives and dairy products. ConstiCare 5mg is generally unsuitable during pregnancy or breastfeeding.
Primary Ingredients of Fynalax 5mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Fynalax 5mg Tablet
Managing Bowel Irregularity
Major Benefits of Fynalax 5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Fynalax 5mg Tablet on an empty stomach.
Common Side effects of Fynalax 5mg Tablet:
- Vomiting
- Bloating
- Nausea
- Stomach cramp
How to use Fynalax 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Fynalax 5mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Fynalax 5mg Tablet works:
Fynalax 5mg tablets provide relief from constipation. Their mechanism of action involves stimulating intestinal motility, promoting bowel regularity.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fynalax 5mg Tablet may pose safety risks; a physician's advice is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Fynalax 5mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of 5mg Fynalax tablets appear compatible. Available data from human studies indicate minimal infant risk associated with this medication.
DrivingUNSAFE
Taking a 5mg Fynalax tablet may induce side effects impairing driving ability. Dizziness and fainting can occur due to a vasovagal reaction, such as abdominal cramping. Patients experiencing abdominal cramping should refrain from driving.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Fynalax 5mg Tablet's efficacy in individuals with impaired renal function. Physician consultation is recommended. Administering Fynalax 5mg Tablet is typically contraindicated in the presence of emesis, due to the potential for dehydration to negatively impact kidney health.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Fynalax 5mg tablets to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Fynalax 5mg Tablet :
Omit any missed Fynalax 5mg Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Fynalax 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane compound |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Behavioral Class | Stimulant-based bowel evacuants |
